Logo image
Sign in
Back
Artificial differences in clostridium difficile infection rates associated with disparity in testing
Journal article   Open access

Artificial differences in clostridium difficile infection rates associated with disparity in testing

M. Kamboj, J. Brite, A. Aslam, J. Kennington, N. E. Babady, D. Calfee, Y. Furuya, D. Chen, M. Augenbraun, B. Ostrowsky, …
Emerging Infectious Diseases, Vol.24(3)
2018
DOI: https://doi.org/10.3201/eid2403.170961

Abstract

Article Clostridium difficile infection diagnostic test diarrhea disease transmission enzyme immunoassay hospital admission hospitalization nonhuman nucleic acid amplification Peptoclostridium difficile prevalence Clostridium infection genetics health disparity health survey hospital human microbiological examination microbiology Bacteriological Techniques Clostridium difficile Clostridium Infections Health Status Disparities Hospitals Humans Nucleic Acid Amplification Techniques Public Health Surveillance
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency. © 2018, Centers for Disease Control and Prevention (CDC). All rights reserved.
url
https://doi.org/10.3201/eid2403.170961View
Published (Version of record) Open

Metrics

1 Record Views

Details